MarketCap
Facebook
X
Telegram
Zealand Pharma A/S ROA | ZEAL
ROA Jährlich Zealand Pharma A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -49.24 | -48.06 | -35.73 | 47.27 | -36.93 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in DKK-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 47.27 | -49.24 | -24.54 |
ROA Vierteljährlich Zealand Pharma A/S
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -108.4 | -108.4 | -108.4 | -108.4 | -144.13 | -94.89 | -94.89 | -94.89 | -47.62 | -37.61 | -26.51 | -26.51 | -49.54 | -13.81 | -13.81 | -13.81 | -32.67 | -79.93 | -79.93 | -79.93 | -38.05 | - | - | - | -23.03 | - | - | - | -18.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in DKK-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -13.81 | -144.13 | -62.78 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Leap Therapeutics
LPTX
|
3.06 | - | 368.57 % | $ 41.9 M |  USA |
 |
Zymeworks
ZYME
|
-54.44 | $ 29.06 | -7.64 % | $ 1.5 B |  Canada |
 |
Adial Pharmaceuticals
ADIL
|
-119.54 | $ 3.15 | -35.42 % | $ 2.11 M | USA |
 |
ADMA Biologics
ADMA
|
23.54 | $ 13.19 | 4.1 % | $ 3.14 B | USA |
 |
Cortexyme
CRTX
|
-89.8 | - | -1.05 % | $ 67.1 M | USA |
 |
Burford Capital Limited
BUR
|
0.94 | $ 3.65 | 0.14 % | $ 800 M |  Britain |
 |
Daré Bioscience
DARE
|
-41.26 | $ 0.71 | 2.5 % | $ 7.94 M | USA |
 |
Fate Therapeutics
FATE
|
-42.74 | $ 1.6 | -9.6 % | $ 190 M | USA |
 |
Greenwich LifeSciences
GLSI
|
-313.34 | $ 16.12 | 0.31 % | $ 218 M | USA |
 |
Halozyme Therapeutics
HALO
|
12.55 | $ 101.68 | -1.26 % | $ 12.2 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
26.06 | $ 15.09 | -1.92 % | $ 13 B |  China |
 |
Aptorum Group Limited
APM
|
-7.29 | - | - | $ 5.72 M | China |
 |
iBio
IBIO
|
-33.13 | $ 0.82 | 5.55 % | $ 85.3 M | USA |
 |
Kodiak Sciences
KOD
|
-65.42 | $ 109.34 | 1.18 % | $ 5.82 B | USA |
 |
Karyopharm Therapeutics
KPTI
|
-180.82 | $ 0.02 | -56.5 % | $ 219 | USA |
 |
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M | Canada |
 |
BioAtla
BCAB
|
-431.06 | $ 1.74 | 0.64 % | $ 102 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
19.41 | - | - | $ 3.85 B | USA |
 |
UroGen Pharma Ltd.
URGN
|
-76.57 | $ 26.14 | 3.24 % | $ 1.26 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
5.95 | $ 14.79 | 6.25 % | $ 1.32 B | USA |
 |
ARCA biopharma
ABIO
|
-21.58 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-11.69 | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
-260.96 | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | USA |
 |
Aileron Therapeutics
ALRN
|
-206.44 | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
2.08 | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | USA |
 |
AVROBIO
AVRO
|
-28406.21 | - | 1083.1 % | $ 745 M | USA |
 |
AstraZeneca PLC
AZN
|
8.97 | - | - | $ 96.9 B | Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
-1008.51 | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
EyePoint Pharmaceuticals
EYPT
|
-63.73 | $ 0.36 | -10.07 % | $ 26.4 K | USA |
 |
Bio-Path Holdings
BPTH
|
-254.8 | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
-56.78 | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
16.34 | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
-93.47 | - | -16.75 % | $ 25.8 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
36.63 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
36.63 | - | -4.36 % | $ 27 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
-117.88 | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
-44.15 | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
-35.83 | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
-4.87 | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
1.93 | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
-87.54 | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
153.4 | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
48.24 | - | 0.77 % | $ 53.4 M | USA |